433 related articles for article (PubMed ID: 23064360)
1. TNF signaling drives myeloid-derived suppressor cell accumulation.
Zhao X; Rong L; Zhao X; Li X; Liu X; Deng J; Wu H; Xu X; Erben U; Wu P; Syrbe U; Sieper J; Qin Z
J Clin Invest; 2012 Nov; 122(11):4094-104. PubMed ID: 23064360
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane tumor necrosis factor-α promotes the recruitment of MDSCs to tumor tissue by upregulating CXCR4 expression via TNFR2.
Ba H; Li B; Li X; Li C; Feng A; Zhu Y; Wang J; Li Z; Yin B
Int Immunopharmacol; 2017 Mar; 44():143-152. PubMed ID: 28092866
[TBL] [Abstract][Full Text] [Related]
3. Cellular FLIP Inhibits Myeloid Cell Activation by Suppressing Selective Innate Signaling.
Wu YJ; Wu YH; Mo ST; Hsiao HW; He YW; Lai MZ
J Immunol; 2015 Sep; 195(6):2612-23. PubMed ID: 26238491
[TBL] [Abstract][Full Text] [Related]
4. TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.
Sharma D; Malik A; Guy C; Vogel P; Kanneganti TD
J Clin Invest; 2019 Jan; 129(1):150-162. PubMed ID: 30457980
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
Calzascia T; Pellegrini M; Hall H; Sabbagh L; Ono N; Elford AR; Mak TW; Ohashi PS
J Clin Invest; 2007 Dec; 117(12):3833-45. PubMed ID: 17992258
[TBL] [Abstract][Full Text] [Related]
7. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer.
Walczak H
Immunol Rev; 2011 Nov; 244(1):9-28. PubMed ID: 22017428
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis.
Shao B; Wei X; Luo M; Yu J; Tong A; Ma X; Ye T; Deng H; Sang Y; Liang X; Ma Y; Wu Q; Du W; Du J; Gao X; Wen Y; Fu P; Shi H; Luo S; Wei Y
Sci Rep; 2015 Nov; 5():16437. PubMed ID: 26561336
[TBL] [Abstract][Full Text] [Related]
10. A chemotactic peptide from laminin alpha 5 functions as a regulator of inflammatory immune responses via TNF alpha-mediated signaling.
Adair-Kirk TL; Atkinson JJ; Kelley DG; Arch RH; Miner JH; Senior RM
J Immunol; 2005 Feb; 174(3):1621-9. PubMed ID: 15661925
[TBL] [Abstract][Full Text] [Related]
11. The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity.
Chen H; Xiao L; Zhang H; Liu N; Liu T; Liu L; Hu X; Yan D; Yang K; Yin B; Wang J; Li Q; Li Z
J Leukoc Biol; 2011 Jun; 89(6):917-26. PubMed ID: 21402772
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.
Parker KH; Sinha P; Horn LA; Clements VK; Yang H; Li J; Tracey KJ; Ostrand-Rosenberg S
Cancer Res; 2014 Oct; 74(20):5723-33. PubMed ID: 25164013
[TBL] [Abstract][Full Text] [Related]
13. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
Twu YC; Gold MR; Teh HS
Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
[TBL] [Abstract][Full Text] [Related]
14. Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling.
Ji W; Li Y; Wan T; Wang J; Zhang H; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2271-9. PubMed ID: 22743059
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
Zhao X; Mohaupt M; Jiang J; Liu S; Li B; Qin Z
Cancer Res; 2007 May; 67(9):4443-50. PubMed ID: 17483359
[TBL] [Abstract][Full Text] [Related]
16. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
Liu Y; Lai L; Chen Q; Song Y; Xu S; Ma F; Wang X; Wang J; Yu H; Cao X; Wang Q
J Immunol; 2012 Jun; 188(11):5500-10. PubMed ID: 22544933
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
19. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.
Yu H; Liu Y; McFarland BC; Deshane JS; Hurst DR; Ponnazhagan S; Benveniste EN; Qin H
Cancer Immunol Res; 2015 Jul; 3(7):727-40. PubMed ID: 25649351
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation.
Sade-Feldman M; Kanterman J; Ish-Shalom E; Elnekave M; Horwitz E; Baniyash M
Immunity; 2013 Mar; 38(3):541-54. PubMed ID: 23477736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
